Long-term outcomes and predictive scores for hepatocellular carcinoma and hepatitis B surface antigen seroclearance after hepatitis B e-antigen seroclearance.
Fung, James; Cheung, Ka-Shing; Wong, Danny Ka-Ho; Mak, Lung-Yi; To, Wai-Pan; Seto, Wai-Kay; Lai, Ching-Lung; Yuen, Man-Fung.
; 68(2): 462-472, 2018 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-29534307
Hepatitis B surface antigen seroclearance: Relationship to hepatitis B e-antigen seroclearance and hepatitis B e-antigen-negative hepatitis.
Hepatitis B surface antigen levels after hepatitis B e-antigen seroclearance: a longitudinal follow-up study.
Factors associated with natural seroclearance of hepatitis B surface antigen and prognosis after seroclearance: a prospective follow-up study.
Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time.
Distinct seromarkers predict different milestones of chronic hepatitis B progression.
Decreasing levels of HBsAg predict HBsAg seroclearance in patients with inactive chronic hepatitis B virus infection.
Positive Rate of Different Hepatitis B Virus Serological Markers in Peking Union Medical College Hospital, a General Tertiary Hospital in Beijing.
Dynamic Characteristics of Serum Hepatitis B Surface Antigen in Chinese Chronic Hepatitis B Patients Receiving 7 Years of Entecavir Therapy.
[Clinical analysis of de novo HBV infection after liver transplantation in non-HBV- related liver disease].
Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance.